ARS Pharmaceuticals
SPRY
#6154
Rank
NZ$1.50 B
Marketcap
NZ$15.23
Share price
1.92%
Change (1 day)
-16.03%
Change (1 year)

Market capitalization of ARS Pharmaceuticals (SPRY)

Market cap: NZ$1.50 Billion

As of March 2026 ARS Pharmaceuticals has a market cap of NZ$1.50 Billion. This makes ARS Pharmaceuticals the world's 6154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ARS Pharmaceuticals from 2022 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.50 B-22.5%
2025NZ$1.94 B4.46%
2024NZ$1.85 B123.52%
2023NZ$0.83 B-33.97%
2022NZ$1.25 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of ARS Pharmaceuticals was reported to be:

NZ$1.47 Billion
by Nasdaq info icon info icon
NZ$1.47 Billion
by CompaniesMarketCap info icon info icon